Please login to the form below

Not currently logged in
Email:
Password:

Neopharm

This page shows the latest Neopharm news and features for those working in and with pharma, biotech and healthcare.

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

The Merck agreement comes four years after Fresenius hived off its biotech business to the owners of Israeli group Neopharm, saying it wanted to narrow down its focus to intravenous drugs,

Latest news

  • Fresenius sells biotech business Fresenius sells biotech business

    Fresenius sells biotech business. Germany company's biotechnology arm picked up by Neopharm owners. ... German healthcare group Fresenius has sold its biotech business for an undisclosed amount to the owners of Neopharm, Israel's second-largest pharma

  • Novartis gains licence for GW's Sativex

    Sativex is licensed to Otsuka Pharmaceutical in the US, to Almirall in Europe (excluding the UK), to Bayer HealthCare in the UK and Canada, and to Neopharm Group in Israel/Palestine.

  • Going for gold

    Additionally, NeoPharm's liposomal candidate, LEP-ETU, is expected to enter phase II clinical trials for breast cancer in 2008.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics